Allemannsdata Wiki
Manual search

OCEAN TUNICELL AS

Organization number 922066639 · Aksjeselskap

Programmatic access to company data (JSON)

Source: Firmafakta. Data read and page generated 2026-09-19T02:07:19Z. HTML cache: no-store (TTL 0 seconds). Default TTL for Firmafakta JSON/API responses: 60 seconds.

Facts

Source: Firmafakta, with business data from public registers.

organisasjonsnummer:
922066639
navn:
OCEAN TUNICELL AS
organisasjonsform:
kode:
AS
beskrivelse:
Aksjeselskap
naeringskode1:
kode:
72.100
beskrivelse:
Forskning og eksperimentell utvikling innenfor naturvitenskap og teknikk
antallAnsatte:
6
hjemmeside:
not reported by source
epostadresse:
not reported by source
telefon:
not reported by source
forretningsadresse:
adresse:
Espehaugen 62
poststed:
BLOMSTERDALEN
postnummer:
5258
kommune:
BERGEN
stiftelsesdato:
2018-12-20
registreringsdatoenhetsregisteret:
2019-01-16
aktivitet:
Forskning, utvikling og salg av materialer innen regenerativ medisin.
vedtektsfestetFormaal:
Forskning, utvikling og salg av materialer innen regenerativ medisin.

View the address in Geonorge

Board and other roles

Source: Firmafakta. Also see the separate Brønnøysund lookup under related lookups.

Daglig leder

Regnskapsfører

Revisor

Styre

Owners

Source: Firmafakta shareholder dataset.

  1. OCEAN GEOLOOP AS – 60.25 % (222798 shares, share class: Ordinære aksjer)
  2. CHRISTOFER GUSTAF TROED TROEDSSON – 13.29 % (49128 shares, share class: Ordinære aksjer)
  3. TUNICHOR AS – 9.93 % (36720 shares, share class: Ordinære aksjer)
  4. ERIC MALCOLM THOMPSON – 4.9 % (18120 shares, share class: Ordinære aksjer)
  5. PER-ERIK NORDAL – 3.28 % (12120 shares, share class: Ordinære aksjer)
  6. HANS KRISTIAN HUSTAD – 2.64 % (9765 shares, share class: Ordinære aksjer)
  7. THOROLF MAGNESEN – 1.66 % (6120 shares, share class: Ordinære aksjer)
  8. ALF BJØRSETH – 0.81 % (3000 shares, share class: Ordinære aksjer)
  9. JEAN-MARIE PIERRE BOUQUET – 0.7 % (2571 shares, share class: Ordinære aksjer)
  10. THOMAS AARSTAD – 0.7 % (2571 shares, share class: Ordinære aksjer)
  11. JIEBING LI – 0.41 % (1530 shares, share class: Ordinære aksjer)
  12. SIGURD OLAV HANDELAND – 0.41 % (1530 shares, share class: Ordinære aksjer)
  13. YADONG ZHAO – 0.41 % (1500 shares, share class: Ordinære aksjer)
  14. HELEN ELIZABETH RASTRICK – 0.29 % (1071 shares, share class: Ordinære aksjer)
  15. JON WIGGEN – 0.21 % (765 shares, share class: Ordinære aksjer)
  16. ØYVIND HAUGE – 0.12 % (459 shares, share class: Ordinære aksjer)

Fetch a longer owner list

Company holdings

Grants and support

Sources provided through Firmafakta: Innovation Norway, the EU, the Research Council of Norway and SkatteFUNN.

Innovasjon Norge (0)

No registered grants.

EU-tildelinger (0)

No registered grants.

Forskningsrådet (6)

6 results

  1. id:
    76916
    prosjektnummer:
    346321
    prosjekttittel:
    Vascularizable Marine Hydrogels for Healing and Tissue Repair
    prosjektstart:
    2024
    prosjektslutt:
    2026
    prosjektansvarlig_navn:
    OCEAN TUNICELL AS
    organisasjonsnummer:
    922066639
    sokt_belop:
    Materialteknologi
    tildelt_belop:
    0.0
    virkemiddel:
    Felleskostnader
    aktivitet:
    Utlysningsaktiviteter
  2. id:
    73338
    prosjektnummer:
    336994
    prosjekttittel:
    Bioengineered repair of osteoarthritic cartilage lesions using human chondrospheres in biocompatible marine hydrogels
    prosjektstart:
    2022
    prosjektslutt:
    2025
    prosjektansvarlig_navn:
    OCEAN TUNICELL AS
    organisasjonsnummer:
    922066639
    sokt_belop:
    Funksjonelle materialer
    tildelt_belop:
    0.0
    virkemiddel:
    Felleskostnader
    aktivitet:
    Utlysningsaktiviteter
  3. id:
    63221
    prosjektnummer:
    317790
    prosjekttittel:
    Norwegian Marine Biopolymers as Injectable Hydrogels for Tissue and Organ Repair – TUNIGUIDE
    prosjektstart:
    2021
    prosjektslutt:
    2023
    prosjektansvarlig_navn:
    OCEAN TUNICELL AS
    organisasjonsnummer:
    922066639
    sokt_belop:
    Nanoteknologi
    tildelt_belop:
    0.0
    virkemiddel:
    Programmer
    aktivitet:
    Store programmer
  4. id:
    64156
    prosjektnummer:
    321450
    prosjekttittel:
    Tunicate nanocellulose scaffolded 3D culture systems to improve outcomes in Assisted Reproductive Technologies TUNIART
    prosjektstart:
    2021
    prosjektslutt:
    2024
    prosjektansvarlig_navn:
    OCEAN TUNICELL AS
    organisasjonsnummer:
    922066639
    sokt_belop:
    Nanoteknologi
    tildelt_belop:
    0.0
    virkemiddel:
    Felleskostnader
    aktivitet:
    Utlysningsaktiviteter
  5. id:
    68725
    prosjektnummer:
    327707
    prosjekttittel:
    Tunicate nanocellulose scaffolded 3D culture systems to improve outcomes in Assisted Reproductive Technologies TUNIART
    prosjektstart:
    2021
    prosjektslutt:
    2025
    prosjektansvarlig_navn:
    OCEAN TUNICELL AS
    organisasjonsnummer:
    922066639
    sokt_belop:
    Nanoteknologi
    tildelt_belop:
    0.0
    virkemiddel:
    Felleskostnader
    aktivitet:
    Utlysningsaktiviteter
  6. id:
    68773
    prosjektnummer:
    327782
    prosjekttittel:
    TuniCell-based hydrogels for 3D printing of Cancer tissue models
    prosjektstart:
    2021
    prosjektslutt:
    2024
    prosjektansvarlig_navn:
    OCEAN TUNICELL AS
    organisasjonsnummer:
    922066639
    sokt_belop:
    Funksjonelle materialer
    tildelt_belop:
    0.0
    virkemiddel:
    Felleskostnader
    aktivitet:
    Utlysningsaktiviteter

SkatteFUNN (2)

2 results

  1. id:
    71436
    innsendt_dato:
    2024-08-30
    prosjektnummer:
    1152
    bedriftsnavn:
    OCEAN TUNICELL AS
    prosjekttittel:
    Utvikling av en robust og kvalitetskontrollert prosess og produksjonslinje for tunikat nanocellulose
    organisasjonsnummer:
    922066639
    fylke:
    Vestland
    kommunenavn:
    Bergen
    poststed:
    not reported by source
    soknad_godkjent:
    not reported by source
    soknad_avslatt:
    not reported by source
    vedtaksdato:
    na
    prosjekt_fra_ar:
    2024
    prosjekt_til_ar:
    2025
    sammendrag:
    The business of Ocean TuniCell AS is to provide clinically relevant hydrogel biomaterial that can bridge the gap between the research community and clinicians, to facilitate the translational process in the biomedical field. Our core invention is the production and processing of medical grade tunicate cellulose nanofibrils, TUNICELL, with excellent properties for 3D reconstruction of tissues and organs. In this project we will conduct research to develop a set of unique methodologies to analyze process parameters, fiber characterization, and biocompatibility, in the TUNICELL production line.
  2. id:
    53924
    innsendt_dato:
    2019-08-09
    prosjektnummer:
    305223
    bedriftsnavn:
    OCEAN TUNICELL AS
    prosjekttittel:
    3D Bioprinting of biomimetic pancreas
    organisasjonsnummer:
    922066639
    fylke:
    Vestland
    kommunenavn:
    Bergen
    poststed:
    BERGEN
    soknad_godkjent:
    JA
    soknad_avslatt:
    NEI
    vedtaksdato:
    2019-08-23
    prosjekt_fra_ar:
    2019
    prosjekt_til_ar:
    2021
    sammendrag:
    Type 1 diabetes (T1D) is characterized by progressive loss of insulin-producing beta cells in islets of Langerhans. For diabetes patients, insulin injection is the most common treatment to control blood sugar levels, but it does not cure the disease. In spite of regulated insulin treatment, periods of hyper- and hypoglycemia induce serious vascular- and neurological complications. The mortality rate of patients suffering from T1D is increased by 3-fold compared to the normal population, and was the seventh leading cause of death worldwide in 2016. Beta islet transplantation is used in several hospitals to help patients with T1D. There are, however, limitations to this approach, including limited donor cell supply, efficacy of the treatment, and requirements for immunosuppression to inhibit transplant rejection. Although the rapid development of stem cell technologies gives hope for future unlimited supply of insulin producing beta cells, there have been challenges to find a safe and efficient device for delivery of the cells. 3D bioprinting enables the creation of bioengineering tissue in a highly controlled manner, by simultaneously integrating living cells, biomaterials, and biological cues to provide a customized scaffold. The aim of the project is to design an implantable biomimetic pancreas device using 3D bioprinting with bioinks based on tunicate nanocellulose. The production of medical grade tunicate nanocellulose, TUNICELL, has been developed by Ocean TuniCell AS and exhibits superior physical properties and is highly pure compared to traditional scaffolding biomaterials. The integration with stem cells for a 3D constructed insulin producing device is therefore particularly promising. In this project, the biocompatibility of TUNICELL will be determined and the final 3D printed device evaluated using in vitro and in vivo models.

Subunits

Open positions

count:
0
stillinger:

No results.

Related lookups

How an AI agent should use this page

Ground rule: Navigate with HTML GET links to keep explanations and relationships. Use the page's JSON alternative only when concrete values must be extracted, compared or computed.

How to use the company page

  1. Use the organization number as the stable key.
  2. Distinguish between the company's own facts, roles, owners, holdings and grants.
  3. Follow person and company links to explore the graph; do not assume relations that are not explicitly registered.

Related services

Time: Ownership, roles and status can change. State the source and retrieval time with factual claims.

AI agent? Read the complete navigation and programming guide.